Company at heart of J&J vaccine woes has series of citations

News

FILE – In this March 25, 2021 file photo, a box of the Johnson & Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. A batch of Johnson & Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said late Wednesday, March 31, 2021. The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries. (AP Photo/Ted S. Warren)

(AP) — The company at the center of quality problems that led Johnson & Johnson to discard a batch of its coronavirus vaccine has a string of citations from U.S. health officials for quality control problems.

The little-known pharmaceutical company, Emergent BioSolutons, was a key to Johnson & Johnson’s plan to deliver 100 million doses of its vaccine to the U.S. by the end of May.

But records obtained by The Associated Press show it has been cited repeatedly by the Food and Drug Administration for problems ranging from poorly trained employees to cracked vials and mold around one of its facilities.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.